The New Healthcare Model Powering Medical Plastics Demand
Summary
Subscription-based diagnostic testing is disrupting the healthcare industry, enabling care models driven by continuous biometric monitoring. As recurring testing and wearable integration increase, medical plastics manufacturers are positioned to meet growing demand for single-use consumables, decentralized testing kits and advanced wearable device components.
A new healthcare trend referred to as “biohacking” is introducing a new healthcare monitoring alternative to traditional physician-directed lab work. Consumers can now take a more active role in managing their healthcare experience with the introduction of subscription-based diagnostic testing paired with wearable biometric measurement devices.
The goal of biohacking is to enhance physical stamina and mental clarity, extend the natural lifespan, and prevent disease. This trend, birthed by the COVID-19-era, reflects the consumer drive to be more informed about the body’s fluid state. Diet, sleep and exercise play a critical role in biohacking. The accurate collection and analysis of bio-info is key to unlocking this practice.
New diagnostic testing subscriptions give individuals a more transparent view of their health through recurring biomarker panels, digital dashboards and integrated data insights from wearable biometric measurement devices like WHOOP, Oura, Google’s FitBit and the Apple Watch. To gather consistent information on body patterns, subscription-based diagnostic testing offers blood draw services to trace key healthcare metrics at professional lab companies. At-home sample collection and wearable device usage will play a part in increasing unit volumes across the healthcare supply chain as the trend becomes more widespread.
“Every recurring test will require single-use polymer components and medical packaging. Every decentralized kit depends on sterile plastic parts. Every wearable biosensor relies on precision-molded housings and biocompatible materials,” said Jon Moellendick, Strategic Account Manager, Healthcare at M. Holland. “Diagnostic testing subscriptions are a strategic growth opportunity for medical plastics manufacturers.”
Emerging Healthcare Trend: Subscription-Based Diagnostic Testing
Subscription-based diagnostic testing is redefining how patients interact with lab services. Instead of relying solely on annual checkups, consumers are using diagnostic testing subscriptions to monitor health data and identify trends over time.
Function Health was an early adopter, introducing a membership model with access to more than 100 lab tests annually. By packaging comprehensive biomarker screening into a subscription, the company reframed diagnostics as an ongoing service instead of a one-time clinical event. Members are encouraged to establish personal baselines and retest periodically.
Wearable platforms are accelerating the diagnostic subscription trend. WHOOP’s collaboration with Quest Diagnostics allows users to purchase clinical lab tests directly through the app and integrate results with daily physiological metrics such as sleep, heart rate variability and activity data. The results create a feedback loop where biochemical markers validate or encourage lifestyle changes.
Digital-first companies like Hims & Hers and Amazon are also expanding into the proactive diagnostics market. The Hims & Hers Labs platform provides subscribers with comprehensive biomarker testing and doctor-developed action plans. Recurring panels monitor data points related to heart health, metabolism, hormones, inflammation and stress. Similarly, Amazon One Medical introduced Health Insights early in 2026 to help members interpret routine lab results through personalized analysis and evidence-based recommendations.
Diagnostic testing subscriptions empower users to interpret and act on biomarker data between routine doctor visits.
What Subscription-Based Diagnostic Testing Means for the Healthcare Plastics Industry
The rise of diagnostic testing subscriptions could impact production volumes, device design and performance standards across the healthcare plastics industry.
“Recurring diagnostic schedules fundamentally change the production equation,” said Jon. “Expect to see higher consumables throughput, more decentralized kit components and increasing wearable device complexity. All this will require advanced medical-grade polymers and consistent, scalable supply.”
Increased Volume of Single-Use Diagnostic Consumables and Decentralized Testing Kits
Subscription-based diagnostic testing increases the frequency of sample collection, whether conducted in a clinical lab, retail setting or at home. When patients move from annual to biannual or quarterly testing under subscription-based diagnostic testing models, per-user consumable usage multiplies. Applied across thousands of subscribers, this shift materially increases production requirements for medical components.
Recurring lab panels drive sustained demand for:
- Syringes
- Blood collection tubes and vacutainers
- Lancets and capillary tubes
- Sample vials and specimen containers
- Pipette tips
- Microfluidic cartridges
- Secure specimen transport systems
“The increased demand for testing consumables is a boon for medical plastic manufacturers, but it’s not the only benefit. Subscription-based diagnostic testing also introduces greater demand predictability,” Jon said. “Manufacturers will likely see recurring order cycles aligned with membership renewals and scheduled test intervals, positively impacting forecasting and capacity planning.”
While subscription models improve demand visibility, they also underscore the critical need for material reliability. As testing moves outside traditional clinical settings, usability and safety requirements will become even more critical. At-home collection kits must be intuitive, tamper-resistant and reliably sterile before use. Material selection and product design are key to ensuring decentralized test kits carry out their function safely and effectively.
Expansion of Wearable-Integrated Diagnostics
Diagnostic testing subscriptions are increasingly linked with wearable devices. Data collected by wearable biometric monitoring devices is used to contextualize lab results, identify trends and encourage ongoing testing. Continuous metrics, including heart rate variability, sleep patterns, activity levels and recovery indicators, can be layered with periodic blood biomarker panels to provide a more comprehensive view of individual health.
“Unlike single-use consumables, wearable devices introduce both initial production demand and recurring replacement or upgrade cycles,” said Jon. “As subscriber bases grow, so does the installed base of devices requiring housings, straps, sensor components and packaging.”
Wearable-integrated diagnostics also introduce elevated engineering requirements. Devices must withstand sweat, UV exposure and daily wear while maintaining optical clarity and sensor accuracy. Materials must offer long-term skin compatibility, dimensional stability and resistance to environmental stress cracking.
Key plastic wearable components include:
- Medical-grade straps and enclosures
- Transparent optical windows for sensors
- Skin-contact adhesive films
“Wearable integration adds another layer of sophistication for plastics manufacturers,” Jon added. “Making the right plastic resin choices leads to wearable designs that maintain biocompatibility and deliver constant performance.”
Visit the Healthcare market page to learn how M. Holland can support medical plastic manufacturing for diagnostic testing and subscribe to receive the latest news and insights from our experts.
Frequently Asked Questions
What is subscription-based diagnostic testing?
Subscription-based diagnostic testing provides recurring access to biomarker panels and digital health insights, allowing patients to monitor trends over time instead of relying solely on annual checkups.
How does subscription-based diagnostic testing impact medical plastics demand?
More frequent testing increases demand for single-use consumables such as syringes, collection tubes and specimen containers, as well as durable components used in wearable biometric monitoring devices.
Why do wearable devices matter in the continuous diagnostics market?
Wearable devices generate ongoing physiological data that complements lab results, driving production of precision-molded enclosures, optical components and skin-contact materials.
What should medical plastics manufacturers consider as this market grows?
Manufacturers should prepare for higher production volumes, stricter material performance requirements, biocompatibility standards and more predictable recurring order cycles tied to subscription models.